Work

Biomarker modulation in patients treated with TRC105 in combination with anti-VEGF therapy.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.11546

Authors: Yingmiao Liu, Zhenhua Yuan, Dadong Zhang, Mark D. Starr, John C. Brady, Manoj A. Jivani, Bonne J. Adams, Delia Alvarez, Steven Attia, Toni K. Choueiri, Charles P. Theuer, Kouros Owzar, Herbert Hurwitz, Andrew B. Nixon

Institutions: Duke Medical Center, Duke University, Tracon Pharmaceuticals (United States), Mayo Clinic in Florida, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890986664

Cites:

Cited by: 1

Related to: 10